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Abstract 
Background: Malaria is a public health concern in Haiti, although there are limited data on its burden and case man-
agement. National malaria guidelines updated in 2012 recommend treatment with chloroquine and primaquine. In 
December 2012, a nationally-representative cross-sectional survey of health facilities (HFs) was conducted to deter-
mine malaria prevalence among febrile outpatients and malaria case management quality at baseline before scale-up 
of diagnostics and case management training.
Methods: Among all 833 HFs nationwide, 30 were selected randomly, in proportion to total HFs per region, for 2-day 
evaluations. Survey teams inventoried HF material and human resources. Outpatients of all ages were screened for 
temperature >37.5 °C or history of fever; those without severe symptoms were consented and enrolled. Providers 
evaluated and treated enrolled patients according to HF standards; the survey teams documented provider-ordered 
diagnostic tests and treatment decisions. Facility-based test results [microscopy and malaria rapid diagnostic tests 
(RDTs)] were collected from HF laboratories. Blood smears for gold-standard microscopy, and dried blood spots for 
polymerase chain reaction (PCR) were obtained.
Results: Malaria diagnostic capacity, defined as completing a test for an enrolled patient or having adequate 
resources for RDTs or microscopy, was present in 11 (37 %) HFs. Among 459 outpatients screened, 257 (56 %) were 
febrile, of which 193 (75 %) were eligible, and 153 (80 %) were enrolled. Among 39 patients with facility-level malaria 
test results available on the survey day, 11 (28 %) were positive, of whom 6 (55 %) were treated with an anti-malarial. 
Twenty-seven (95 %) of the 28 patients testing negative were not treated with an anti-malarial. Of 114 patients 
without test results available, 35 (31 %) were presumptively treated for malaria. Altogether, 42 patients were treated 
with an anti-malarial, one (2 %) according to Haiti’s 2012 guidelines. Of 140 gold-standard smears, none were positive, 
although one patient tested positive by PCR, a more sensitive technique. The national prevalence of malaria among 
febrile outpatients is estimated to be 0.5 % (95 % confidence interval 0–1.7 %).
Conclusions: Malaria is an uncommon cause of fever in Haitian outpatients, and limited, often inaccurate, diagnostic 
capacity at baseline contributes to over diagnosis. Scale-up of diagnostics and training on new guidelines should 
improve malaria diagnosis and treatment in Haiti.
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Background
Haiti and the Dominican Republic share the island of 
Hispaniola, the only Caribbean island where malaria 
remains endemic. Despite a significant malaria eradica-
tion effort in the 1960s, which dramatically reduced its 
prevalence, malaria remains a public health challenge 
for Hispaniola. Funding for malaria activities in Haiti 
has been limited since 1988 when the National Malaria 
Eradication Service (Service Nationale de l’Eradication de 
la Malaria) was incorporated into the primary care sys-
tem. However, in 2011 a five-year award was granted by 
the Global Fund to Fight AIDS, Tuberculosis and Malaria 
(GFATM) to improve malaria control in Haiti. This 
award committed funds to multiple priorities, including: 
national distribution of long-lasting insecticide-treated 
mosquito nets; deployment of widespread vector-control 
measures; improvement of malaria diagnostics; updat-
ing the national treatment guidelines; and strengthening 
malaria case management [1].
Malaria case management, which is comprised of test-
ing patients with suspected malaria and providing appro-
priate treatment to confirmed case-patients, is a central 
element of malaria control. In 2010, the Haitian Ministry 
of Public Health and Population (Ministère de la Santé 
Publique et de la Population, MSPP) approved three 
brands of malaria rapid diagnostic tests (RDTs) to extend 
diagnostic capacity beyond microscopy [2]. Furthermore, 
in 2012, Haiti revised its malaria diagnosis and treatment 
guidelines, adding recommendations to confirm all cases 
of suspected malaria by a parasitological diagnostic test 
and to include a single dose of primaquine (0.75  mg/
kg) in combination with standard chloroquine therapy 
(25 mg/kg total, administered over 3 days) for treatment 
of all confirmed malaria cases. Prior to this revision, it 
was typical to diagnose malaria based on clinical symp-
toms including history of fever with or without other 
symptoms such as nausea, vomiting, diarrhoea, head-
ache, back pain, chills, and myalgia, for which other obvi-
ous causes were excluded. The recommendation for this 
two-drug regimen was made with the goal of reducing 
malaria transmission via the gametocytocidal activity of 
primaquine [1], and aligned the malaria treatment poli-
cies across Hispaniola [3].
Multiple health system factors play a role in malaria 
case management (Fig.  1), and many of these same ele-
ments have been historically under-resourced in Haiti. 
Although high-quality historical data on many health 
system factors are lacking for Haiti, a few evaluations of 
diagnostic capacity at local health facilities have demon-
strated a low positive predictive value of microscopy at 
health facility laboratories (22 and 40  %) compared to 
reference laboratories [4, 5]. Understanding the barriers 
to good case management should facilitate appropriate 
resource targeting for programme improvement.
A key indicator to guide malaria control programmes 
is malaria infection prevalence measured in two pop-
ulations: (1) febrile patients seeking care at health 
facilities, measured by routine surveillance or health 
Fig. 1 Steps in malaria case management
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facility-based surveys; and (2) community members 
who are generally asymptomatic, measured by house-
hold surveys. Previous surveys in health facilities and 
communities have provided a range of estimates. In 
Haiti, health facility surveys, conducted in 1995, 2005, 
and 2007, generally using non-representative sam-
pling designs, reported microscopy-based malaria 
prevalence rates among febrile outpatients that were 
between 3.5 and 4.9  % [3–5]. A convenience sample 
of febrile persons presenting to a non-representative 
sample of mobile clinics in the months immediately 
following the 2010 earthquake demonstrated a malaria 
infection prevalence of 20.3 % by RDT [6]. Community 
malaria assessments conducted along the coastline of 
Haiti’s southern peninsula identified parasitemic indi-
viduals [7, 8]. A community-based survey conducted in 
the Artibonite Valley during the rainy season of 2006 
estimated a 3.1% prevalence of malaria by polymerase 
chain reaction (PCR) [9]. In 2011, a national commu-
nity survey showed that, by all methods (microscopy, 
RDT and PCR), less than one percent of persons were 
parasitemic [10].
In late 2012, the MSPP through the national malaria 
control programme (Programme National de Contrôle de 
la Malaria, PNCM) and the national public health labora-
tory (Laboratoire National de Santé Publique, LNSP), in 
partnership with Population Services International (PSI) 
and the US Centers for Disease Control and Prevention 
(CDC) conducted a survey to measure malaria preva-
lence among febrile patients seeking care at health facili-
ties, and to evaluate diagnostic and treatment practices. 
This survey was funded by the GFATM malaria grant 
with the intention of providing baseline values for key 
programmatic indicators before widespread dissemina-
tion of training on the revised guidelines and RDTs.
Methods
Survey context and design
According to Haiti’s 2011 health facility census, its 
health care system includes approximately 800 health 
facilities distributed among 10 departments [11]. About 
half of these facilities are dispensaires (outpatient clin-
ics typically staffed by those with a nursing degree 
equivalent), and about one quarter are centres sans lits 
(outpatient clinics often with limited beds for short 
observation and staffed by at least one physician). The 
remainder are centres avec lits (facilities with inpa-
tient services and one or more physician) or hospitals 
(facilities with inpatient wards, and specialized services 
and staff ). All types of facilities offer outpatient ser-
vices. While most hospitals have laboratories on-site, 
laboratory capacity varies among other types of health 
facilities.
Study design
This nationally representative, cross-sectional survey of 
febrile outpatients used a stratified cluster-sampling design 
where the primary sampling units, or clusters, were facili-
ties in each department (or stratum). From each stratum, 
a sample of health facilities was randomly selected in pro-
portion to the number of total facilities in each department. 
The sampling frame of health facilities for this evaluation 
included 833 functional facilities with outpatient services, 
identified in the MSPP national health facility census report 
of 2011 [11]. All eligible febrile patients presenting for out-
patient consultations at the sampled health facility during 
regular working hours on the survey day were eligible for 
enrolment. Reliable patient volume data was not available 
when the survey was planned; therefore, facilities were not 
selected in proportion to their utilization.
Enrolment
Criteria for patient enrolment in the study were: (1) 
experiencing fever, defined as a measured temperature 
≥37.5 °C, or history of fever at any time during the pre-
vious 2 weeks, (2) being aged 18 years or older, or hav-
ing a guardian present who was 18 years or older, and (3) 
providing informed consent. Patients were excluded from 
participation if they had signs of severe disease, specifi-
cally: impaired consciousness, prostration, intractable 
vomiting, convulsions, respiratory distress, shock, jaun-
dice, or spontaneous bleeding [12].
Sample size
A sample size of 533 enrolled subjects was calculated to 
detect a malaria prevalence of 50  % with a precision of 
±5 %, taking into account a type 1 error of 0.05, a design 
effect of 1.25, and a non-participation rate of 10 %. The 
malaria prevalence estimate was chosen to provide the 
most conservative estimate of sample size, and was 
informed by a post-earthquake survey which demon-
strated a malaria prevalence of 20.3  % among febrile 
patients [6], much higher than had been observed in pre-
vious health facility surveys [3–5] which raised uncer-
tainty about the true burden of malaria in this population. 
Thirty facilities were sampled across the 10 departments 
in Haiti (Fig. 2) to ensure an appropriate minimum num-
ber of units to account for clustering at the facility-level.
Survey procedures
The field work for the survey was conducted between 
December 7 and 14, 2012. Each health facility visit was 
unannounced and took place over two consecutive days. 
On the first day, the survey teams conducted a quan-
titative inventory of the facility’s physical and human 
resources, and performed interviews with all available 
and consenting health care providers in the outpatient 
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department. For the facility inventory, the survey teams 
utilized a standardized data collection instrument to 
assess resources in outpatient clinics, laboratories, and 
pharmacies. A second day was dedicated to an outpa-
tient survey where patients presenting to the facility’s 
outpatient clinic were screened for fever. Eligible, con-
senting, febrile patients were enrolled and finger-prick 
blood samples were collected to prepare thick and thin 
blood smears from each subject. These blood smears 
were reserved for later interpretation at the LNSP, and 
were considered the gold standard. In addition, several 
drops of blood from each participant were collected onto 
Whatman 903 protein saver cards for PCR to assess sub-
microscopic parasitaemia. Each patient was evaluated 
and treated per facility standard of care by the provider 
and laboratory. After the clinical encounter, the pro-
vider was asked to complete a short form on each study 
participant describing the diagnosis, tests ordered, and 
treatments prescribed for febrile illness, including anti-
malarial drugs. Occasionally, if the provider was unable 
to fill out the form, it was completed by the survey team 
based on the clinical note completed by the provider. 
Enrolled patients were administered a post-consultation 
questionnaire to assess illness history, mosquito net own-
ership, and malaria knowledge.
Laboratory procedures
Laboratory diagnosis of malaria was performed at two 
levels: (1) by the facility laboratory using microscopy if 
operational, or by RDTs if available; and (2) by the LNSP 
reference laboratory, which analysed survey-prepared 
blood smears from enrolled patients as the “gold stand-
ard”. Facility laboratory results were documented by the 
survey team if the laboratory completed and recorded 
the results by the end of the clinic day. Gold-standard 
microscopy was performed according to a standard 
protocol [13]. Briefly, after fixation of the thin smear in 
methanol, thin and thick smears were stained with 10 % 
Giemsa for 5–10 min. The survey-prepared blood slides, 
were double read by two expert, microscopists at the ref-
erence laboratory who were blinded to the facility labora-
tory results. The examination of slides began in January 
2013, approximately 1  month after preparation in the 
field. In order to declare a microscopy specimen free of 
Plasmodium falciparum infection, 300–500 thick-smear 
fields were examined.
Dried blood spots, on Whatman 903 protein saver 
cards, were analysed in duplicate by LNSP in June 2014 by 
polymerase chain reaction using photo-induced electron 
transfer fluorogenic genus-specific primers (PET-PCR). 
Sample preparation, storage, extraction, and assays were 
Fig. 2 Map of sampled health facilities in Haiti
Page 5 of 12Landman et al. Malar J  (2015) 14:394 
performed using protocols described previously [10, 14], 
but modified to account for World Health Organization 
(WHO) Evidence Review Group recommendations made 
in March 2014 for PCR analysis in low transmission set-
tings [15]. Briefly, the amplification of Plasmodium genus 
(5′–3′, forward primer: GCTCTTTCTTGATTTCTTG-
GATG; reverse primer: FAM-aggcgcatagcgcctgg 
AGCAGGTTAAGATCTCGTTCG) was performed in 
a 30  µL reaction containing 2X TaqMan Environmental 
buffer 2.0 (Applied BioSystems, Grand Island, NY, USA), 
400  nm each of forward and reverse primers. For each 
sample, duplicate PET-PCR reactions were run with 6 
µL of DNA template used in the PCR reaction with the 
following cycling parameters: initialization at 95  °C for 
15 min, followed by 45 cycles of denaturation at 95 °C for 
15 s, annealing at 63 °C for 60 s. The correct fluorescence 
channel was selected for FAM dye and the cycle thresh-
old (CT) values recorded at the end of annealing step. 
All assays were performed using Applied Biosystems 
ABI 7500 or StepOne thermocyclers (Life Technologies, 
Carlsbad, CA, USA). Cycle threshold values, which are 
continuous, semi-quantitative measurements of parasite 
load, were obtained for all specimens. Those with CT val-
ues of less than 40.0 were considered positive for malaria.
Positive samples were subjected to additional testing 
by nested 18S rRNA PCR (nPCR) to confirm the Plas-
modium species, utilizing a method previously described 
by Singh et al. [16]. Briefly, both primary and secondary 
PCR reactions were performed using 2 µL of DNA tem-
plate in 25 µL total volume containing 1X buffer, 2.5 mM 
MgCl2, 200 µM dNTPs, 200 nM primers, and 1.25 units 
of Taq Polymerase (New England Biolabs, Ipswich, MA, 
USA). The products were analysed for appropriate band 
size on a 2 % agarose gel with a positive showing a single 
visible band.
Data management and analysis
Data were entered using Epi Info™ 7 (7.1.1.14) (CDC, 
Atlanta, GA, USA) and Microsoft Excel for Windows 7 
(Microsoft, Redmond, WA, USA). Analysis was per-
formed with SAS 9.3 (SAS Institute, Cary, NC, USA) 
and involved simple counts and percentages. National 
estimates and 95 % confidence intervals (CI) were calcu-
lated using patient-level or health facility-level weights as 
appropriate using the SAS PROC SURVEYFREQ proce-
dure in order to account for the complex sampling design. 
Sensitivity and specificity analyses were conducted com-
paring facility diagnostic results to the survey-performed 
gold-standard microscopy. The map was created using 
ARCGIS 10.2.2 (Esri, Redlands, CA, USA) using spatial 
data of health facilities courtesy of the Haitian Institute of 
Statistics and Informatics (Institut Haïtien de Statistiques 
et d’Informatiques) and National Center of Geo-spatial 
Information Systems (Centre National de l’Information 
Géo-Spatiale).
Definitions
For the purposes of this survey, health facilities were 
defined as having the capacity to diagnose malaria if they 
fulfilled the following criteria: (1) a facility laboratory 
completed a malaria test on the survey day for at least 
one enrolled patient using either an RDT or a microscopy 
examination of a blood smear, or (2) the survey inven-
tory results determined that there was on-site capacity 
to perform either microscopy (functional microscope, 
reliable electricity, staining reagents, and a trained labo-
ratory technician) or RDTs (current stock of any one of 
the three MSPP-approved RDT brands and at least one 
employee trained in performing RDTs). Reliable elec-
tricity was defined as having electricity for four or more 
hours a day, 5 days a week or having at least one genera-
tor in the hospital.
“Treatment according to guidelines” referred to direc-
tives set in the MSPP 2012 malaria treatment policy 
and was defined as: (1) prescription of the correct dose 
of chloroquine and primaquine to those with a positive 
malaria test result, and (2) no prescription of anti-malar-
ials to those with a negative test result [1]. For treatment 
doses, the total adult regimen is 1500 mg of chloroquine 
base (administered over 3 days, with four tablets contain-
ing 150 mg each given on day one, and three tablets given 
on days two and three) and a single dose of 0.75 mg/kg 
primaquine (maximum adult dosage is 45  mg) on the 
first day of treatment. Paediatric regimens are adjusted 
according to age and weight [1]. The MSPP/PNCM sup-
plies tablets containing 150 mg of chloroquine base and 
7.5 mg tablets of primaquine.
Human subjects review
The survey protocol and questionnaire were reviewed 
and approved by the human subjects review boards of 
the MSPP (reference number 1112-30) and the US Cent-
ers for Disease Control and Prevention (Atlanta, GA, 
USA). Written consent was obtained from each subject, 
or from guardians accompanying subjects younger than 




Figure 2 shows a map of the thirty health facilities sam-
pled proportionally across all ten Departments; of these 
19 offered outpatient services only (14 were dispensaires, 
and five were centres sans lits); 11 facilities offered both 
outpatient and inpatient services (five were centres avec 
lits, and six were hôpitaux). Figure  3 shows the flow 
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chart for participant enrolment. Four hundred and fifty-
nine patients presenting to the sampled outpatient clin-
ics on the day of the survey were screened for inclusion. 
Two hundred and fifty-seven (56  %) patients had either 
an axillary temperature ≥37.5  °C at evaluation or a his-
tory of fever. Of these, 64 were ineligible because they 
were below the age of consent and did not have a guard-
ian present (n = 9, 4 %) or because they had symptoms 
consistent with severe illness (n = 55, 21 %). Of the 193 
eligible patients, 40 (16 %) patients refused, resulting in 
153 (79 %) enrolled patients.
Table  1 describes the participant characteristics. The 
mean age of enrolled patients was 22.6 years, median was 
22 years, with a range of 3 months to 80 years old. It was 
more common for patients to be female (n = 103, 68 %), 
and 13 women were pregnant (9  % of all participants). 
Sixty-one percent of patients owned any mosquito net 
(n  =  94), and of these, 63 reported sleeping under a 
net the previous night (68  %). More than two-thirds of 
patients (or caregivers) correctly indicated that mosqui-
toes transmit malaria (n = 104, 68 %). Additional patient 
characteristics are shown in Table 1.
Provider characteristics
One hundred and fifteen providers were interviewed, 
of whom 102 provided direct patient care and were 
included in our analysis. Providers reported a mean 
4.3 years of medical training (range 0–12, median of 3), 
and 61 (60 %) providers were female. Fifty (49 %) provid-
ers had received in-service training in the case manage-
ment of malaria or severe malaria, and 16 (14 %) had this 
training in 2012, after the malaria treatment guidelines 
had been revised.
Malaria case management
Malaria diagnostic capacity of health facilities is shown in 
Table 2. Eleven (37 %) facilities surveyed had diagnostic 
capacity on the basis of having completed malaria test-
ing of at least one patient. According to inventory results, 
eight (27 %) and two (7 %) facilities had the materials and 
personnel necessary to conduct either microscopy or 
RDT, respectively. Eighteen (60 %) facilities reported hav-
ing electricity at least 4 h a day, 5 days a week; six (20 %) 
facilities had neither electricity nor a generator. Adequate 
supplies and equipment for microscopy were present in 
11 (37 %) facilities. Three (10 %) facilities had at least one 
brand of RDT in stock (≥1 test) on the day of the sur-
vey. Of these, two had an approved brand and two had 
non-approved brands; one facility had both an approved 
and a non-approved brand in stock. Five (19 %) facilities 
previously had RDTs available, but were out of stock on 
the day of the survey. Among these facilities, three (60 %) 
used an approved brand, one used a non-approved brand, 
Table 1 Enrolled patient characteristics
N number of responses
Characteristic n/N (%)
Aged <5 years 39/146 (27)
Female 103/152 (68)
Pregnant 13/149 (9)
Live in urban area 64/148 (43)
Days symptomatic
 ≤3 days 47/151 (31)
 4–7 days 51/151 (34)
 8–14 days 30/151 (20)
 >14 days 23/151 (15)
Days febrile
 ≤3 days 53/146 (36)
 4–7 days 49/146 (34)
 8–14 days 28/146 (19)
 >14 days 16/146 (11)
Own a mosquito net 94/153 (61)
Slept under mosquito net last night 63/92 (68)
Knows that mosquitoes transmit malaria 104/153 (68)
Sought care at health facility first 100/152 (66)
Education
 Primary school or less 84/152 (55)
 Secondary school or more 68/152 (45)
Time to travel to facility
 <30 min 71/151 (47)
 30–60 min 36/151 (24)
 1–2 h 38/151 (25)
 >2 h 6/151 (4)
Satisfied with care received 128/149 (86)
Fig. 3 Flow chart of patient enrolment
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and one could not specify the brand. Thirteen facilities 
(43  %) had at least one provider or laboratory techni-
cian trained to perform RDTs. Altogether, 16 (53  %) of 
30 facilities had the ability to diagnose malaria, and 91 
(59  %) enrolled patients were seen at facilities with this 
capacity.
Training on malaria microscopy, RDTs and current 
MSPP malaria guidelines was reported by the facilities, 
according to health worker cadre (health care provider 
or laboratory technician). Trained microscopy laboratory 
technicians were staffed at 16 (53 %) facilities (Table 2). 
For RDTs, a total of 13 (43 %) facilities had at least one 
staff (of any cadre) trained; seven facilities had at least 
one laboratory technician trained, nine facilities had at 
least one clinical health provider trained, and three facili-
ties had both laboratory technicians and health provid-
ers trained on RDTs. Fifteen facilities (50  %) reported 
that personnel (of any cadre) were trained on the malaria 
treatment guidelines. Of these, 14 facilities had at least 
one clinical health provider trained; seven facilities had 
both providers and laboratory technicians trained on the 
new guidelines, and one facility had only a laboratory 
technician trained on the new guidelines.
Data on the ordering and completion of malaria tests 
are shown in Fig. 4. Malaria test ordering practices were 
assessed using the post-consultation form completed 
by health care providers. Among the 91 febrile patients 
seen in 16 facilities with malaria diagnostic capacity, 53 
(58 %) had a malaria test ordered by a provider (45 [50 %] 
microscopy, and 16 [18  %] RDT). At 14 facilities with-
out diagnostic capacity, nine (15 %) of 62 patients had an 
order written for a test to be done at an outside labora-
tory: all nine included an order for microscopy, and eight 
included an RDT order.
Laboratory registers at facilities with diagnostic 
capacity were reviewed to obtain malaria test results 
for enrolled patients (Fig.  4). Fifty-one (96  %) of the 53 
patients with an order for a diagnostic test had a test 
initiated in the facility laboratory, and 39 (76 %) of these 
patients had a laboratory result recorded at the end of the 
survey day, in time for clinical decision-making. Eleven 
(28 %) patients with completed tests were found positive 
by the facility for malaria. Malaria diagnostic tests were 
not done for 102 (67 %) of the enrolled patients.
Among the 51 patients tested for malaria, 56 tests were 
initiated (five patients had both a microscopy and RDT 
test performed), including 46 smears and ten RDTs. Of 
the smears, 24 (52 %) were read as negative by the facility 
laboratory, ten (22 %) were read as positive, and 12 (26 %) 
did not have results recorded in the laboratory results 
register by the end of the survey day and were considered 
unavailable for clinical decision-making. Of the ten RDTs 
performed, nine (90 %) were negative and one (10 %) was 
positive. The patient with a positive RDT did not have 
a blood smear performed in the facility laboratory, and 
the brand of the RDT used was not one of the approved 
brands.
The 2012 malaria treatment guidelines made two fun-
damental changes to the treatment recommendations: (1) 
only confirmed patients should be treated with an anti-
malarial; and (2) a single dose of primaquine is given, in 
addition to the 3-day regimen of chloroquine.
To assess treatment decisions, anti-malarial prescrip-
tions are shown in Fig.  5 for two groups: patients with 
test results available in time for clinical decision-making 
(n =  39), and patients without a test result (n =  114), 
either because a test was initiated but results were una-
vailable (n = 12) or because no test was done (n = 102). 
Among 39 patients with results available, 33 (85 %) were 
treated in accordance with their test result. However, five 
(45 %) of 11 patients with a positive test result from the 
facility laboratory were not treated with an anti-malar-
ial, and one (4 %) of 28 patients with a negative test was 
treated with an anti-malarial. Of the 114 patients with no 
test results, 35 (31 %) were treated presumptively with an 
anti-malarial.
Table 2 Facilities with malaria diagnostic capacity
Definition Criteria for malaria diagnostic capacity Facilities n (%)
1 Test conducted during the survey: ≥1 blood smear or RDT done and results available in facility laboratory 11 (37)
2 Malaria microscopy capacity: adequate laboratory and electrical supply 8 (27)
Adequate laboratory supplies and equipment (≥1 working microscope, Giemsa stain and glass slides) 11 (37)
Adequate electrical supply (electricity at least 5 days/week and ≥4 h/day or generator) 18 (60)
Trained microscopy technician 16 (53)
3 RDT diagnosis: stock of an approved RDT and >1 health worker trained on them 2 (7)
≥1 approved RDT in stock (CareStart, First Response, Bioline) 2 (7)
≥1 provider trained in performing RDTs 13 (43)
1, 2, 3 Diagnostic capacity by any definition 16 (53)
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A total of 42 (27 %) patients were prescribed any anti-
malarial, and all of them included chloroquine. Six (4 %) 
patients were also prescribed primaquine, of which one 
(17 %) was prescribed the correct adult dosage (45 mg), 
and three were prescribed a higher dose according to 
age and weight charts. In all cases of incorrect pre-
scription of primaquine, the tablet size documented 
(75 mg as primaquine phosphate salt) was similar to the 
Fig. 4 Flow chart for malaria testing
Fig. 5 Flow chart of testing results and antimalarial treatments
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recommended total milligrams-per-kilogram dose of 
primaquine (0.75 mg/kg). Since primaquine is not avail-
able in tablets of this size, it is unclear if these reported 
overdoses represent true overdoses or reporting error. Of 
all patients treated with any anti-malarial, only one (2 %) 
was treated with a correct dose of chloroquine and pri-
maquine according to the national guidelines.
Gold‑standard microscopy results, PCR, and sensitivity 
and specificity of facility testing
The reference laboratory examined 153 gold-standard 
blood smears prepared by the survey team, of which 13 
could not be read due to poor staining or fixation, or due 
to degradation of the stain in the interval period. Of the 
remaining 140, none were positive for any Plasmodium 
species. Specimens from 33 patients had results avail-
able from both the gold-standard survey microscopy and 
the facility laboratory. However, since no ‘true positives’ 
were identified by the survey microscopy, it was not pos-
sible to calculate the sensitivity for facility-read blood 
smears. Specificity of the facility results was 70 % (95 % 
CI 51–84 %).
PET-PCR was performed at LNSP on dried blood spots 
from each of the 153 enrolled patients. One sample was 
positive with duplicate CT values of 39.0 and 39.1, which 
are just under the CT cutoff threshold for positivity of 
≤40. Calibration assessments using the PET-PCR proto-
col described herein have determined that a CT value of 
34 corresponds to approximately 100 parasites per micro-
litre, and therefore specimens with CT values between 34 
and 40 are generally considered below the threshold of 
detection by traditional microscopy and most commer-
cial RDTs (unpublished observations, E. Rogier, JW Barn-
well, V. Udhayakumar). Nested PCR was conducted at 
the CDC-Atlanta malaria laboratory and confirmed that 
this specimen contained a single-species infection with P. 
falciparum. The patient from whom the sample had been 
obtained was a 28-year old male seen in a facility in Port-
au-Prince, who had previously sought care elsewhere and 
may have had prior treatment. On the survey day, a blood 
smear and RDT were ordered; the RDT was positive, 
but the facility microscopy result was not available. The 
patient was treated with chloroquine alone on the survey 
day. The gold standard blood smear was negative.
National estimates
Table  3 shows the national estimates calculated for key 
indicators. The national estimate of the prevalence of 
malaria among patients seeking care at health facilities, 
detected by PCR, was 0.5 % (95 % CI 0.0–1.7). Two crite-
ria were used to classify patients as being managed by the 
health facilities according to 2012 national guidelines: (1) 
those with positive malaria test results (from the facility) 
and prescribed the correct dose of chloroquine and pri-
maquine (n = 1), and (2) those with negative test results 
not prescribed any anti-malarial (n =  27). The national 
estimate for febrile patients being treated according to 
the 2012 guidelines is 16  % (95  % CI 0.0–39). Patients 
with malaria results available for clinical decision-making 
was estimated at 17 % (95 % CI 0.0–40).
Health facilities with diagnostic capacity for malaria 
were estimated at 56 % (95 % CI 36–77), and 45 % (95 % 
CI 26–65) of health facilities were estimated to have a 
provider trained to use RDTs.
Twenty-three percent (95  % CI 11–36) of health pro-
viders were trained on RDTs, and 16  % (95  % CI 9–23) 
of them were trained on malaria treatment guidelines in 
2012.
Discussion
This study provides baseline findings on the quality of 
malaria case management in Haiti and the health system 
factors affecting it, prior to implementation of national 
training and distribution of malaria treatment guidelines 
and RDTs. Critically, a low proportion (53 %) of facilities 
had diagnostic capacity for malaria (Table 2). While the 
possession of microscopes among health facilities was 
relatively high (70  % data not shown), unreliable elec-
tricity and an inconsistent supply of reagents and slides 
contributed to the low capacity of facilities to diagnose 
Table 3 National estimates of key indicators
Indicator Point estimate (%) 95 % confidence interval
Patients with malaria detectable by PCR 0.5 0–1.7
Patients managed according to 2012 national guidelines 16 0–39
Patients with malaria test result available for clinical decision-making 17 0–40
Facilities with malaria diagnostic capacity 56 36–77
Facilities having a provider trained in RDT use 45 26–65
Health providers trained on RDTs 23 11–36
Health providers trained in 2012 on malaria treatment guidelines 16 9–23
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malaria by microscopy. Similarly, only two (7 %) facilities 
had stock of an approved RDTs for malaria diagnosis.
Additionally, there was a substantial volume of pre-
sumptive malaria treatment without laboratory-con-
firmed diagnosis—almost one third of patients not 
tested for malaria were treated with an anti-malarial 
(Fig. 5). However, as malaria is responsible for a minor-
ity of fevers in Haiti it is necessary to confirm cases of 
malaria with high-quality diagnostic tests prior to pro-
viding treatment. The utilization of RDTs, which can be 
performed in the absence of a laboratory and read at the 
point of care, may reduce these missed opportunities 
for malaria confirmation, but access to this commodity 
needs to be improved. Presumptive malaria treatment 
impedes diagnosis and treatment of the true cause of 
febrile illness, and results in an overestimate of malaria 
burden, which affects prioritization of resources for pub-
lic health interventions.
Conversely, 45 % of patients in this survey who tested 
positive for malaria at the facilities were not treated with 
an anti-malarial on the survey-day (Fig. 5). It is possible 
that inefficient intra-facility communication between the 
laboratories and providers may have contributed to the 
discrepancy between the positive malaria test results and 
the lack of anti-malarial prescriptions. Continual train-
ing on the updated malaria treatment guidelines should 
emphasize to providers the importance of using the 
results from malaria tests, especially RDTs, on the first 
day of the clinical visit to inform diagnoses and medica-
tion prescriptions. Facility and regional leadership should 
be engaged to find local solutions to intra-facility com-
munication problems, and promote all clinical staff to 
adhere to the malaria guidelines to test and treat on the 
day of clinical presentation.
In this survey, facility laboratory results showed a high 
number of false positive tests: none of the 11 patients 
who tested positive (10 according to microscopy tests, 
and 1 according to RDT) for malaria at the facility-level 
had smear-confirmed malaria according to the national 
reference laboratory. Earlier health facility-based surveys 
demonstrated low positive predictive values of Haitian 
health facility microscopy for malaria ranging from 22 to 
40 % [4, 5], thus the current findings suggest that the lack 
of proficient microscopy in many health facilities in Haiti 
is an ongoing problem. Given the resources necessary to 
develop and maintain expertise to conduct widespread 
microscopy for malaria diagnosis, RDTs may be the best 
choice to extend malaria diagnostic capacity in Haiti, as 
in other low-transmission settings [17].
Notably, the one RDT positive result was confirmed by 
PET-PCR as a low-density malaria infection, resulting in 
a national estimate of malaria prevalence among febrile 
outpatients of 0.5 (95  % CI 0–1.7  %). This sample was 
negative by microscopy. There are several possible expla-
nations for this discrepancy. First, multiple studies have 
demonstrated that PCR is far more sensitive than micros-
copy, especially in contexts of lower levels of malaria 
transmission; in one meta-analysis, among studies where 
population malaria prevalence was <10  %, microscopy 
detected only 12  % of infections detected by PCR [18]. 
However, given the processing time, cost, and demand 
for specialized equipment, trained personnel, and steady 
electrical supply, PCR is not practical as a diagnostic 
tool, especially in low resource settings. Second, RDTs 
detect circulating parasite antigen which can remain after 
an active infection is cleared, and thus it is possible for 
RDTs to detect a recent infection in an individual clini-
cally cured within the previous 2  weeks; this limitation 
could be partially resolved if providers ask about recent 
treatment for malaria. There is a suggestion that due to 
this mechanism, RDTs are more likely than microscopy 
to detect low-density infections [19].
All anti-malarial regimens prescribed by health work-
ers in this survey included chloroquine. However, a 
minority of patients were also treated with single-dose 
primaquine, which was recently added to the first-line 
regimen in the 2012 national guidelines. Overall, only 
one of 42 patients prescribed an anti-malarial was treated 
with the correctly dosed regimen of chloroquine plus 
primaquine.
According to study records, three of the six patients 
prescribed primaquine had documented doses greater 
than those recommended for age and weight, likely 
attributable to confusion between tablet size and total 
recommended dosage. Ongoing provider training should 
clarify the primaquine dosing and tablet sizes available to 
avoid potential overdoses, which can be especially dan-
gerous to individuals with glucose-6-phosphate dehydro-
genase deficiencies.
This evaluation has several limitations. In accordance 
with the design of this study, only persons who presented 
to health facilities on the survey day were evaluated. 
Access to health care is a pervasive problem in Haiti, 
with 82 % of women aged 15–49 years claiming at least 
one barrier to accessing care (permission to get care, 
money for treatment, distance to a facility, not wanting 
to go alone) [20]. In addition, available data did not per-
mit selection of health facilities on the basis of utilization, 
although this limitation was minimized in the calcula-
tion of national estimates by weighting the final sample 
according to utilization rates ascertained during survey 
procedures.
It is possible that some portion of the over-diagnosis 
and over-treatment observed could be attributable to 
the Hawthorne effect related to health care workers’ 
knowledge of the presence of surveyors associated with 
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the malaria programme [21]; although the survey was 
not announced prior to the arrival of the survey teams, 
health care workers were aware of the teams’ affiliation 
and may have wanted to appear vigilant with respect to 
the evaluation and treatment of malaria. However, this 
phenomenon would not have impacted the gold standard 
blood smear results.
An additional limitation is the relatively large num-
ber of screened patients who were excluded due to 
self-report of symptoms of severe disease. Despite 
efforts to correctly translate severe symptoms into 
Haitian Creole, there may have been misinterpreta-
tion of the translated medical terms; omission of these 
patients may have resulted in an underestimation of 
malaria cases in general, and severe malaria in particu-
lar. Exclusion of patients for other reasons, including 
refusal to participate, may have resulted in participa-
tion bias. Finally, although effort was made to mini-
mize differences in survey teams’ methods, missing 
data, reporting inaccuracies, and variability of meth-
ods between teams may also have affected this study’s 
internal validity.
Conclusions
This survey found high levels of clinical diagnosis and 
presumptive treatment of malaria by health workers, as 
well as low levels of correct anti-malarial prescription 
for those patients diagnosed with malaria. The reasons 
for these findings likely include poor diagnostic capac-
ity and a low level of health care provider training for 
malaria diagnostics and treatment on the revised guide-
lines. Priorities for the malaria programme and partners 
going forward include wide-reaching training on and 
implementation of a limited number of high-quality, 
easy-to-use RDT brands, and improvement in provider 
training and supervision on Haiti’s updated treatment 
guidelines. This study provided a baseline estimation of 
health system factors contributing to malaria case man-
agement in Haiti, prior to programme scale-up, and 
highlights opportunities to direct programme resources 
for improved performance. A subsequent health facility 
survey was conducted in late 2014 to assess programme 
progress.
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